title: New recreational drugs and the primary care approach to patients who use them.
authors.affiliation: South London and Maudsley NHS Trust, Institute of Psychiatry King's College London, Blackfriars Road Community Drug and Alcohol Team, UK. adam.winstock@slam.nhs.uk
authors.forename: Adam R
authors.initials: AR
authors.lastname: Winstock
authors.forename: Luke
authors.initials: L
authors.lastname: Mitcheson
mesh_terms: D000470:Alkaloids / Q000009:adverse effects; D000778:Anesthetics, Dissociative / Q000009:adverse effects; D018686:Anesthetics, Intravenous / Q000009:adverse effects; D002072:Butylene Glycols / Q000009:adverse effects; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects*; D007649:Ketamine / Q000009:adverse effects; D011320:Primary Health Care; D012017:Referral and Consultation; D012978:Sodium Oxybate / Q000009:adverse effects; D019966:Substance-Related Disorders / Q000175:diagnosis* / Q000628:therapy
chemical_list: D000470:Alkaloids; D000778:Anesthetics, Dissociative; D018686:Anesthetics, Intravenous; D002072:Butylene Glycols; D000697:Central Nervous System Stimulants; D013287:Illicit Drugs; C023665:cathinone; D007649:Ketamine; D012978:Sodium Oxybate; C039681:1,4-butanediol